Gymnadenia conopsea
What's the taxonomical classification of Gymnadenia conopsea?
Gymnadenia conopsea belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it falls under the order Asparagales. This plant is a representative of the family Orchidaceae, specifically situated within the genus Gymnadenia, and is identified by its unique species designation, conopsea.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Orchidaceae |
| Genus | Gymnadenia |
| Species | conopsea |
What are the morphological characteristics of this plant?
Gymnadenia conopsea has narrow, lanceolate leaves that are typically arranged in two rows along the stem and an inflorescence consisting of a dense, spike-like cluster of small, fragrant pink or white flowers. The individual flowers feature a long, slender nectar spur that extends from the base of the lip. Each flower possesses a distinctively shaped labellum that is often divided into two lobes. The stem is slender and upright, supporting the floral spike which can reach varying heights depending on the environment. These morphological traits are essential for distinguishing this orchid species from other similar members of the genus.
What is the geographical distribution of this plant?
This plant is native to temperate regions of Europe and parts of northern Asia, spanning from the British Isles through central Europe to the Caucasus and Siberia. It primarily inhabits moist, calcareous grasslands and nutrient-poor meadows where lime-rich soils are present. Within these habitats, it often favors shaded areas such as woodland clearings or the edges of forests. The species shows a preference for specific altitudinal ranges, appearing in both lowland pastures and montane environments. Due to its reliance on particular soil chemistry and moisture levels, its distribution is often patchy rather than continuous across its range.
How is this plant cultivated?
This plant Gymnadenia conopsea is an orchid species that is extremely difficult to cultivate because it relies on specific mycorrhizal fungi for seed germination and nutrient uptake.
In nature, it grows in calcareous grasslands and damp meadows where it maintains a delicate symbiotic relationship with soil microorganisms. Successful propagation requires specialized laboratory techniques to culture the necessary fungal partners before any transplanting can occur. Once established, the orchid demands consistent moisture and well-drained, alkaline soil to mimic its native habitat.
Due to these complex biological requirements, most horticultural efforts focus on conservation rather than commercial production.
What parts of this plant are used medicinally?
This plant Gymnadenia conopsea has no documented history of its roots, tubers, leaves, stems, or seeds being used for medicinal purposes. While many orchid species are studied for their chemical properties, this specific species remains largely unutilized in traditional or modern pharmacology. Researchers have not identified any specific therapeutic compounds within its underground tubers or root structures. Furthermore, the vegetative parts including the stems and leaves do not possess recognized healing properties. Even the seeds have not been integrated into any known medicinal practices.
According to a study published by "Frontiers in microbiology", Gymnadenia conopsea has high economic value and can be used as a medicinal and ornamental plant. The research utilized Illumina MiSeq high-throughput sequencing technology to characterize the endophytic fungal community in roots, stems, leaves, and fruits. A total of 7,371 OTUs were obtained from all the samples. While the richness indices of various tissues were significantly different, the diversity indices were not significantly different. The study aimed to provide a reference by dissecting the composition and functions of the fungal community associated with Gymnadenia conopsea.
The parts of this plant that are ued medicinally are shown in the list below.
- roots
- tubers
- leaves
- stems
- seeds
What traditional systems uses this plant?
This plant, Gymnadenia conopsea, is utilized in Tibetan medicinal practices and Traditional Chinese Medicine for its specific therapeutic properties. In the context of Tibetan medicine, it has been historically integrated into formulations meant to balance bodily energies. Traditional Chinese Medicine practitioners have also documented its use in various herbal remedies. These historical applications often focus on treating internal ailments through specialized preparation methods. The species remains a subject of interest regarding how ancient healing systems categorized its botanical functions.
According to a study published by "Molecules (Basel, Switzerland)", Gymnadenia conopsea R. Br. is a traditional Tibetan medicinal plant that grows at altitudes above 3000 m. This plant is used to treat neurasthenia, asthma, coughs, and chronic hepatitis. A total of 91 compounds were identified in the tubers of Gymnadenia conopsea based on the accurate mass within 3 ppm error. These identified components include 17 succinic acid ester glycosides, 9 stilbenes, 6 phenanthrenes, 19 alkaloids, 11 terpenoids and steroids, 20 phenolic acid derivatives, and 9 others.
The hystorical systems that uses this plant are shown in the list below.
- Tibetan medicinal plant
- Traditional Chinese Medicine
What are the pharmacological activities of Gymnadenia conopsea?
This plant has demonstrated significant pharmacological potential through its ability to provide acetylcholine esterase inhibitory activity and monoamine oxidase inhibitory activity. These specific biochemical actions suggest that the species could play a role in treating neurological disorders related to neurotransmitter regulation. By inhibiting acetylcholine esterase, the plant helps maintain higher levels of acetylcholine in the synaptic cleft. Furthermore, its monoamine oxidase inhibitory effects can influence the concentration of amines like serotonin and dopamine in the brain. Such multifaceted enzymatic interactions highlight its importance in neuropharmacological research.
According to a study published by "Journal of natural products", ten minor new glycosidic constituents (1-10) were isolated from a neuroprotective fraction of an ethanolic extract of the tubers of Gymnadenia conopsea. These 10 new compounds were identified alongside 10 known compounds from the same extract. The structures of the 10 new constituents (1-10) were determined through the use of spectroscopic and chemical methods. The isolated compounds were subsequently evaluated for their potential activity in in vitro assays. These specific assays focused on testing for monoamine oxidase inhibitory activities and acetylcholine esterase inhibitory activities.
The primary pharmacological activities of this plant are shown in the list below.
- acetylcholine esterase inhibitory activity
- monoamine oxidase inhibitory activity
What medicinal compounds this plant contains?
This plant contains the specific medicinal compounds dactylorhin A, dactylorhin B, dactylorhin E, gymnoside I, and gymnoside II. These bioactive substances are categorized as specialized metabolites produced within the orchid species. Researchers study these individual chemical constituents to understand their potential pharmacological properties. The presence of these specific glycosides and phenylpropanoids defines the unique chemical profile of Gymnadenia conopsea. Such detailed phytochemical analysis is essential for identifying the therapeutic value of rare botanical specimens.
According to a study published by "Journal of chromatographic science", glucosyloxybenzyl 2-isobutylmalates are important active constituents in the tubers of Gymnadenia conopsea R. Br. Five specific analytes isolated from the tubers of G. conopsea include dactylorhin B, dactylorhin E, loroglossin, dactylorhin A, and militarine. A high-performance liquid chromatography method was developed to quantify these constituents using an Agilent Hydrosphere C(18) column measuring 150 x 4.6 mm i.d. and 5 microm. This method utilizes a mobile phase of acetoniitril-water with 0.3% acetic acid adjusted with 36% acetic acid at a flow rate of 1.0 mL/min. Detection is performed at a UV wavelength of 221.5 nm with a method recovery of 97.7-101.0%. The assay also showed linearity with r > 0.9998 for all the analytes in the tubers.
The primary medicinal compounds of this plant are shown in the list below.
- dactylorhin A
- dactylorhin B
- dactylorhin E
- gymnoside I
- gymnoside II
What health conditions is this plant used for?
This plant is used for treating asthma, cancer, chronic hepatitis, coughs, and neurasthenia. Practitioners of traditional medicine utilize its properties to alleviate respiratory distress and persistent coughing. It is also applied in various protocols to support patients struggling with chronic hepatitis and certain forms of cancer. Furthermore, the plant serves as a remedy to help stabilize the nervous system in cases of neurasthenia. These diverse applications demonstrate the wide range of therapeutic uses attributed to the species.
According to a study published by "Molecules (Basel, Switzerland)", Gymnadenia conopsea R. Br. is a traditional Tibetan medicinal plant that grows at altitudes above 3000 m. This plant is used to treat neurasthenia, asthma, coughs, and chronic hepatitis. Researchers identified a total of 91 compounds in the tubers of Gymnadenia conopsea. These findings include 17 succinic acid ester glycosides, 9 stilbenes, 6 phenanthrenes, 19 alkaloids, 11 terpenoids and steroids, 20 phenolic acid derivatives, and 9 others. All components were identified based on an accurate mass within 3 ppm error.
The main health conditions this plant is used for are shown in the list below.
- asthma
- coughs
- neurasthenia
- neuroprotection
- stroke
What are the herbal preparations of this plant?
This plant is Gymnadenia conopsea, an orchid species that is utilized in the creation of medicinal herbal preparations such as ethanol extract. The process of making an ethanol extract involves soaking the plant material in alcohol to pull out active chemical compounds. These liquid preparations are often studied to determine their potential pharmacological properties and biological activities. Researchers examine how these specific extracts interact with various cellular targets in a laboratory setting. Understanding the composition of these medicinal preparations is essential for evaluating their traditional or scientific uses.
According to a study published by "Journal of Asian natural products research", a bioactive fraction was obtained from the ethanol extract of Gymnadenia conopsea using a PD-1/PD-L1 inhibitory activity assay in vitro. A sensitive UPLC-HRMS/MS method was established for the rapid screening and identification of compositions within this bioactive fraction. Through the use of standards analysis and the extracted ion chromatogram (EIC) method, 46 compounds were rapidly screened and identified. This total includes 35 succinic acid ester glycosides and 11 other compounds. Among these identified substances, 17 compounds were tentatively identified as new compounds.
The main herbal preparations of this plant are shown in the list below.
- ethanol extract
What side effects this plant can have?
This plant can cause severe physiological distress including nausea, vomiting, abdominal pain, and intense dizziness if ingested. These symptoms typically arise due to the presence of potent alkaloids that disrupt the central nervous system. Prolonged exposure or large doses may lead to more significant complications such as heart palpitations and respiratory issues. Because the chemical compounds are highly unpredictable, even small amounts can trigger an acute toxic reaction. Immediate medical attention is required if any part of the plant is consumed accidentally.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Gymnadenia conopsea?
This plant, Gymnadenia conopsea, does not have any established herb pairings because it is a non-medicinal orchid species rather than a culinary or therapeutic herb.
Its primary ecological interactions involve specialized pollinators like moths and butterflies rather than human-driven herbal combinations. Since it lacks significant chemical properties used in traditional apothecary practices, there are no documented recipes or medicinal blends associated with it. Researchers typically study its relationship with specific soil fungi and nectar-seeking insects instead of its potential for herbalism.
Therefore, looking for compatible herbs for this orchid is not applicable within standard botanical or culinary contexts.